Gene · 28234
SLCO1B3: solute carrier organic anion transporter family member 1B3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SLCO1B3: solute carrier organic anion transporter family member 1B3. Genes, record 28234. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/28234
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | 702 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents44
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026067851 A | 2026-04-21 | 379 | Q9NPD5 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 64890 | Q9NPD5 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 64891 | Q9NPD5 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1435 | Q9NPD5 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 4327 | Q9NPD5 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 4327 | Q9NPD5 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1435 | Q9NPD5 | Espacenet |
| EP 4556017 A1 | 2025-05-21 | 1 | Q9NPD5 | Espacenet |
| JP 2023521663 A | 2023-05-25 | 378 | Q9NPD5 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 82285 | Q9NPD5 | Espacenet |
1 to 10 of 44
See all 44 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants987
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SLCO1B3 papers | Newest fiscal year |
|---|---|---|---|
| R35GM122576 | Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy | 15 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 12 | 2025 |
| P30ES006694 | Southwest Environmental Health Sciences Center | 11 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 10 | 2025 |
| ZIABC010453 | Genetics and Molecular Mechanisms of Prostate Cancer | 10 | 2025 |
| ZIABC010627 | Clinical Pharmacogenetics | 10 | 2025 |
| T32ES007091 | Training in Environmental Toxicology of Human Disease | 9 | 2025 |
| U24CA247648 | The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN | 9 | 2025 |
| P30DK026743 | UCSF Liver Center | 8 | 2025 |
| P01CA163227 | Androgen Receptor Action in Castration Resistant Prostate Cancer | 7 | 2025 |
1 to 10 of 987Source NIH's project files
See all 987 nih grantsPapers2,854
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Analysis a patient with Dubin-Johnson syndrome due to a rare c.4120C>T nonsense variant of ABCC2 gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2026 | 42711131 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic Modeling to Assess Transporter-Mediated Drug-Drug Interactions in Support of Labeling Recommendations for Zavegepant Nasal Spray. | Clin Pharmacol Ther | 2026 | 42698006 | PubTator, text mining | PubMed |
| In vitro assessments for pharmacokinetic drug-drug interaction potential of vornorexant, a novel dual orexin 1/2 receptor antagonist. | Xenobiotica | 2026 | 42693680 | PubTator, text mining | PubMed |
| Impact of SLCO1B3 767G>C (rs60140950) polymorphism on paclitaxel response in Iraqi women with breast cancer. | J Taibah Univ Med Sci | 2026 | 42676853 | PubTator, text mining | PubMed |
| Identification of Gln422 in transmembrane domain 9 as a key amino acid residue for the selective transport of ginsenoside Re by organic anion transporting polypeptide 1B3. | Drug Metab Dispos | 2026 | 42664884 | PubTator, text mining | PubMed |
| Clinical and Genetic Determinants of Hepatocellular Carcinoma in a Turkish Cohort: Impact of SLCO1B1 and SLCO1B3 Germline Variations and Demographic Risk Factors. | Int J Mol Sci | 2026 | 42511559 | PubTator, text mining | PubMed |
| Transcriptomics-driven non-invasive liquid biopsy for diagnosing peritoneal lavage cytology-positive gastric cancer. | NPJ Precis Oncol | 2026 | 42457866 | PubTator, text mining | PubMed |
| Pediatric acute liver failure in a child with arsenic toxicity and underlying rotor syndrome. | Oxf Med Case Reports | 2026 | 42422268 | PubTator, text mining | PubMed |
| Serum benzylpenicillin levels during treatment for amatoxin poisoning: pharmacokinetic support for OATP1B3 inhibition. | Clin Toxicol (Phila) | 2026 | 42396640 | PubTator, text mining | PubMed |
| Quantification of Binding of Small Molecules to Native Kinases by Flow Cytometry Reveals Divergence from Biochemical Affinities. | J Am Chem Soc | 2026 | 42336767 | PubTator, text mining | PubMed |
1 to 10 of 2,854
See all 2,854 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/28234
GET https://conductscience.org/api/genes/v1/28234/patents?page=2